+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Hypercholesterolemia - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Hypercholesterolemia - Global Clinical Trials Review, 2024

  • Clinical Trials
  • May 2024
  • 1282 Pages
  • Global
From
Pneumococcal Meningitis - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Pneumococcal Meningitis - Global Clinical Trials Review, 2024

  • Clinical Trials
  • May 2024
  • 63 Pages
  • Global
From
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • May 2024
  • 102 Pages
  • Global
From
Androgenic Alopecia: Competitive Landscape - Product Thumbnail Image

Androgenic Alopecia: Competitive Landscape

  • Report
  • May 2024
  • 72 Pages
  • Global
From
Vitiligo: Competitive Landscape - Product Thumbnail Image

Vitiligo: Competitive Landscape

  • Report
  • May 2024
  • 67 Pages
  • Global
From
Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032 - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032

  • Report
  • May 2024
  • 75 Pages
  • Global
From
Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update - Product Thumbnail Image

Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update

  • Report
  • May 2024
  • 92 Pages
  • Global
From
Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis

  • Report
  • May 2024
  • 93 Pages
  • Global
From
Aortic and Vascular Graft Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Aortic and Vascular Graft Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • May 2024
  • 54 Pages
  • Global
From
Osteoporosis: Epidemiology Forecast to 2033 - Product Thumbnail Image

Osteoporosis: Epidemiology Forecast to 2033

  • Report
  • May 2024
  • 41 Pages
  • Global
From
Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast - Product Thumbnail Image

Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast

  • Report
  • May 2024
  • 16 Pages
  • Global
From
Cell & Gene Therapies in Rheumatology: Therapeutic Analysis - Product Thumbnail Image

Cell & Gene Therapies in Rheumatology: Therapeutic Analysis

  • Report
  • April 2024
  • 45 Pages
  • Global
From
Psychedelics Therapeutics Development and Trends, 2024 - Product Thumbnail Image

Psychedelics Therapeutics Development and Trends, 2024

  • Report
  • April 2024
  • 36 Pages
  • Global
From
Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • March 2024
  • 115 Pages
  • Global
From
Arthralgia (Joint Pain) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Arthralgia (Joint Pain) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • March 2024
  • 397 Pages
  • Global
From
Rare Disease ?Pipeline Analysis ?Landscape in 2023 - Product Thumbnail Image

Rare Disease ?Pipeline Analysis ?Landscape in 2023

  • Drug Pipelines
  • February 2024
  • 29 Pages
  • Global
From
Mucopolysaccharidosis II (Mps II) (Hunter Syndrome ) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Mucopolysaccharidosis II (Mps II) (Hunter Syndrome ) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • February 2024
  • 83 Pages
  • Global
From
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (Her2- Breast Cancer) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (Her2- Breast Cancer) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • February 2024
  • 1264 Pages
  • Global
From
Ankylosing Spondylitis (Bekhterev's Disease) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Ankylosing Spondylitis (Bekhterev's Disease) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • January 2024
  • 595 Pages
  • Global
From
Major Depressive Disorder: 68-Market Analysis and Sales Forecast - Product Thumbnail Image

Major Depressive Disorder: 68-Market Analysis and Sales Forecast

  • Report
  • January 2024
  • 17 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more